ID: ALA4452660

Max Phase: Preclinical

Molecular Formula: C49H75N13O21

Molecular Weight: 1182.21

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O

Standard InChI:  InChI=1S/C49H75N13O21/c1-21(2)12-27(43(76)58-29(14-24-6-8-25(65)9-7-24)45(78)57-26(10-11-34(50)66)42(75)61-32(49(82)83)15-35(51)67)55-36(68)18-53-41(74)30(16-38(70)71)59-47(80)33(20-63)62-46(79)31(17-39(72)73)60-44(77)28(13-22(3)4)56-37(69)19-54-48(81)40(52)23(5)64/h6-9,21-23,26-33,40,63-65H,10-20,52H2,1-5H3,(H2,50,66)(H2,51,67)(H,53,74)(H,54,81)(H,55,68)(H,56,69)(H,57,78)(H,58,76)(H,59,80)(H,60,77)(H,61,75)(H,62,79)(H,70,71)(H,72,73)(H,82,83)/t23-,26+,27+,28+,29+,30+,31+,32+,33+,40+/m1/s1

Standard InChI Key:  JQQLHEJTTIUEQZ-BIHPYDIESA-N

Associated Targets(Human)

OVCAR-3 48710 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-OV-3 52876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1182.21Molecular Weight (Monoisotopic): 1181.5200AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Miao Q, Ma K, Chen D, Wu X, Jiang S..  (2019)  Targeting tropomyosin receptor kinase for cancer therapy.,  175  [PMID:31077998] [10.1016/j.ejmech.2019.04.053]

Source